Investing.com -- Morgan Stanley upgraded Veeva Systems to Equal-weight, saying competitive risks in its core customer relationship management business are now better understood after a sharp share ...
Veeva Systems (NYSE:VEEV) is one of the best 52-week low blue-chip stocks to buy right now. On January 29, Veeva Systems (NYSE:VEEV) unveiled Veeva eSource, a new Veeva SiteVault tailored to eliminate ...
Veeva Systems (VEEV) is drawing fresh attention after a sharp pullback in information technology stocks tied to fears of artificial intelligence disruption, even as new life sciences customers ...
PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement ...
Veeva Systems Inc Class A stock reached a 52-week low of $201.51, marking a significant point in its trading history. Over the past year, Veeva Systems has experienced a decline in its stock value, ...
As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...
The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...
The Details: Veeva reported quarterly earnings of $2.04 per share, which beat the analyst estimate of $1.95. Quarterly revenue of $811.2 million beat the Street estimate of $792.82 million.
Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results